Zoloft and Pregnancy
The Food and Drug Administration issued a warning in July 2006 about the risk of birth defects associated with the use of Zoloft during pregnancy. After studies found that the use of Zoloft by pregnant women could lead to serious birth defects, the agency advised patients who are pregnant or may become pregnant to talk with their doctor about whether the should continue taking the drug.
Multiple studies published by the New England Journal of Medicine have uncovered a link between Zoloft and pregnancy complications. Women who use Zoloft during the first trimester face an increased risk of giving birth to a child with ventricular outflow tract obstruction defects, hypoplastic left heart syndrome, ventricular septal defects, atrial septal defects, tetralogy of Fallot, transposition of the great arteries and coarctation of the aorta.
In a separate study, researchers found that the use of Zoloft during the third trimester of pregnancy could increase the risk of giving birth to a child with persistent pulmonary hypertension of the newborn (PPHN). Women who took Zoloft after the 20th week of pregnancy were six times more likely to give birth to a child with PPHN than non-patients.
Many women who were taking Zoloft during pregnancy and gave birth to a child with birth defects have filed Zoloft lawsuits against the manufacturer of the drug. In spite of the warnings and lawsuits concerning Zoloft, the FDA has not announced plans to recall Zoloft due to its link with heart defects and other birth defects.
If you or a loved one used Zoloft while pregnant and gave birth to a baby with heart defects or other congenital birth defects, you may qualify to file a lawsuit and receive compensation. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling us toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.